Get ahead of your highs and lows. Maintain your cadence throughout the day.
Did you know that the VA covers Guardian™ Connect CGM? Fill out the form below to get started.
Terms and conditions apply.∆
Continuous glucose monitoring, or CGM, is a way to measure glucose levels in real-time throughout the day and night. Now you can see how your sugar levels are trending and be alerted before your sugars go high or low.†
A member of our team will reach out to you for additional information. If you have questions please contact us at 1-888-882-8602 (M-F 9 AM-6 PM CT).
† The Guardian™ Sensor 3 glucose values are not intended to be used directly for making therapy adjustments, but rather to provide an indication of when a fingerstick may be required.
∆ Participating healthcare professionals offer the On Demand program which enables their patients to start using the Guardian™ Connect system at no charge for 30 days. Restrictions apply.
Participation in the Guardian™ Connect CGM System Patient Evaluation Program (“Evaluation Program”) is designed to increase your working knowledge of the Guardian™ Connect CGM System. As a participant in the Evaluation Program, you will have the opportunity to experience and wear the Guardian™ Connect CGM System for up to thirty (30) days following completion of training. Prior to participating, you must review and sign the Patient Evaluation Program Agreement acknowledging your understanding of the potential risks associated with the Guardian™ Connect CGM System and agreeing to the terms and conditions of the Evaluation Program.
Potential risks and discomforts that may occur during this evaluation are associated with reactions to the physical presence of the sensor, including skin irritation, bruising, redness, allergic reaction to the tape, bleeding at the site, and site infection. If irritation of the insertion site occurs, remove the sensor and consult with your healthcare professional.
Important Safety Information: Guardian™ Connect CGM System
The Guardian™ Connect system requires a prescription and is indicated for continuous or periodic monitoring of glucose levels in the interstitial fluid under the skin, in patients (14 to 75 years of age) with diabetes mellitus. The system is intended to complement, not replace, information obtained from standard blood glucose monitoring devices, and is not recommended for people who are unwilling or unable to perform a minimum of two meter blood glucose tests per day, or for people who are unable or unwilling to maintain contact with their healthcare professional. The system requires a functioning mobile electronic device with correct settings. If the mobile device is not set up or used correctly, you may not receive sensor glucose information or alerts. For complete details of the system and its components, including warnings, contraindications, and precautions, please consult the user guide and important safety information.